The aftermath of the Merck's HIV vaccine trial

The recently released results of the Merck's Phase IIb "test-of concept" vaccine trials have shown no protection from HIV-1 infection in the vaccinated group compared with a control group vaccinated with placebo. The study was designed to test the Merck's MRKAd5 trivalent candida...

Descripción completa

Detalles Bibliográficos
Autores principales: Iaccino, Enrico, Schiavone, Marco, Fiume, Giuseppe, Quinto, Ileana, Scala, Giuseppe
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2483718/
https://www.ncbi.nlm.nih.gov/pubmed/18597681
http://dx.doi.org/10.1186/1742-4690-5-56

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2483718/
https://www.ncbi.nlm.nih.gov/pubmed/18597681
http://dx.doi.org/10.1186/1742-4690-5-56

Ejemplares similares